Daewoong pharmaceutical (069620.KS) Earnings Analysis
Daewoong pharmaceutical (069620.KS) next reports earnings on 2026-08-18. It has beaten estimates in 0/3 recent quarters (0%). Trailing P/E 7.13.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 069620.KS next report earnings?
| Next earnings date | 2026-08-18 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | 398.30B |
069620.KS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-09 | 7,807.9 KRW | n/a | n/a | n/a |
| 2025-11-14 | 4,030.02 KRW | n/a | n/a | n/a |
| 2025-04-28 | 1,903 KRW | 2,329.77 KRW | -18.3% | Miss |
| 2025-02-10 | -1,115.1 KRW | 2,375.27 KRW | -146.9% | Miss |
| 2024-08-09 | 99 KRW | 2,224.46 KRW | -95.5% | Miss |
Beat rate: 0/3 (0%) over reported quarters with consensus data.
069620.KS valuation and analyst view
| Trailing P/E | 7.13 |
|---|---|
| Trailing EPS | 17,248.81 KRW |
| Price / book | 1.40 |
| Dividend yield | 0.48% |
| Market cap | 1377.30B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Daewoong pharmaceutical (069620.KS)'s next earnings date?
Daewoong pharmaceutical is next scheduled to report on 2026-08-18 and revenue estimate of 398.30B.
Did 069620.KS beat earnings last quarter?
Consensus estimate data was not available for 069620.KS's 2026-02-09 report.
What is 069620.KS's earnings track record?
Over the last 3 reported quarters with consensus data, 069620.KS beat estimates 0 times (0%).
What is 069620.KS's current P/E ratio and EPS?
069620.KS trades at a trailing P/E of 7.13 on trailing EPS of 17248.812289634934 KRW.
What do analysts rate 069620.KS?
069620.KS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.